Brookstone Capital Management Has $2.23 Million Holdings in CME Group Inc. (NASDAQ:CME)

Brookstone Capital Management decreased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 75.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,413 shares of the financial services provider's stock after selling 26,150 shares during the quarter. Brookstone Capital Management's holdings in CME Group were worth $2,232,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of CME. SeaCrest Wealth Management LLC grew its stake in CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after buying an additional 40 shares during the last quarter. New Age Alpha Advisors LLC boosted its holdings in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares during the period. Wealthcare Advisory Partners LLC boosted its holdings in CME Group by 3.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock valued at $356,000 after purchasing an additional 47 shares during the period. Koshinski Asset Management Inc. boosted its position in shares of CME Group by 1.4% during the 1st quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock valued at $934,000 after acquiring an additional 48 shares in the last quarter. Finally, Berry Wealth Group LP boosted its position in shares of CME Group by 0.4% during the 1st quarter. Berry Wealth Group LP now owns 13,561 shares of the financial services provider's stock valued at $3,598,000 after acquiring an additional 49 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CME shares. JPMorgan Chase & Co. cut their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Bank of America lifted their price target on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Raymond James Financial raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target for the company in a report on Monday, March 10th. Finally, UBS Group boosted their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, CME Group currently has a consensus rating of "Hold" and a consensus target price of $259.87.

Insider Activity

In other news, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the transaction, the director owned 5,400 shares in the company, valued at $1,471,824. This represents a 35.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Larry G. Gerdes sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, April 24th. The shares were sold at an average price of $264.10, for a total transaction of $528,200.00. Following the completion of the transaction, the director owned 38,651 shares of the company's stock, valued at $10,207,729.10. This trade represents a 4.92% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is currently owned by company insiders.

CME Group Trading Up 2.1%

Shares of NASDAQ:CME traded up $5.85 during trading on Monday, hitting $282.55. 2,252,300 shares of the company's stock were exchanged, compared to its average volume of 2,189,580. CME Group Inc. has a 1-year low of $193.17 and a 1-year high of $290.79. The firm has a 50-day moving average price of $276.40 and a two-hundred day moving average price of $258.18. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $101.82 billion, a P/E ratio of 28.43, a PEG ratio of 3.75 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.50 earnings per share. Equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date was Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.